Trial Details
RECRUITINGBasic Information
| Clinical ID | c1161 |
|---|---|
| Identifier | NCT06581328 |
| Trial Title | A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: Vedolizumab IV|DRUG: Vedolizumab SC |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Glen Burnie |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-03-27 |
|---|---|
| Primary Completion Date | 2027-10-01 |
| Completion Date | 2028-06-01 |